Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
Jennifer W. Evans, Joanna Szczepanik, Nancy E. Brutsché, et al.
Biological Psychiatry (2018) Vol. 84, Iss. 8, pp. 582-590
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 786
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Rebecca B. Price, Ronald S. Duman
Molecular Psychiatry (2019) Vol. 25, Iss. 3, pp. 530-543
Open Access | Times Cited: 485
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
Anees Bahji, Gustavo Vázquez, Carlos A. Zarate
Journal of Affective Disorders (2020) Vol. 278, pp. 542-555
Open Access | Times Cited: 302
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave, Timothy A. Troppoli, Andreas B. Wulff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 271
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder, Sara Costi, Sarah Rutter, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 2, pp. 193-202
Closed Access | Times Cited: 172
The role of dissociation in ketamine’s antidepressant effects
Elizabeth D. Ballard, Carlos A. Zarate
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 142
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 64
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
Prediction on treatment improvement in depression with resting state connectivity: A coordinate-based meta-analysis
Zhiliang Long, Lian Du, Jia Zhao, et al.
Journal of Affective Disorders (2020) Vol. 276, pp. 62-68
Closed Access | Times Cited: 122
Psychedelic drugs—a new era in psychiatry?
David Nutt
Dialogues in Clinical Neuroscience (2019) Vol. 21, Iss. 2, pp. 139-147
Open Access | Times Cited: 108
The Insula: A Brain Stimulation Target for the Treatment of Addiction
Christine Ibrahim, Dafna Sara Rubin-Kahana, Abhiram Pushparaj, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 107
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 93
Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
Anahit Mkrtchian, Jennifer W. Evans, Christoph Kraus, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3292-3301
Open Access | Times Cited: 83
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu, Maximillian Greenwald, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 8-21
Open Access | Times Cited: 81
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A. Zarate, Gustavo Vázquez
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 853-866
Open Access | Times Cited: 42
Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
Songbai Xu, Xiaoxiao Yao, Bingjin Li, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 39
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 35
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
Jared M. Kopelman, Timothy A. Keller, Benjamin Panny, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 32
(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
Rei Yokoyama, Yukio Ago, Hisato Igarashi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1406-1416
Open Access | Times Cited: 13
The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
Meysam Amidfar, Marie Woelfer, Gislaine Z. Réus, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 94, pp. 109668-109668
Closed Access | Times Cited: 76
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
Molly C. Kalmoe, Alvin M. Janski, Charles F. Zorumski, et al.
Journal of the Neurological Sciences (2020) Vol. 412, pp. 116778-116778
Open Access | Times Cited: 63
Functional connectivity between prefrontal cortex and subgenual cingulate predicts antidepressant effects of ketamine
Matti Gärtner, Sabine Aust, Malek Bajbouj, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 4, pp. 501-508
Open Access | Times Cited: 56
Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex
Marie Woelfer, Meng Li, Lejla Čolić, et al.
The World Journal of Biological Psychiatry (2019) Vol. 21, Iss. 9, pp. 696-710
Closed Access | Times Cited: 56
The emergence of ketamine as a novel treatment for posttraumatic stress disorder
Adriana Feder, Sarah Rutter, Daniela Schiller, et al.
Advances in pharmacology (2020), pp. 261-286
Closed Access | Times Cited: 56
Abnormal core functional connectivity on the pathology of MDD and antidepressant treatment: A systematic review
Jianxiu Li, Junhao Chen, Wenwen Kong, et al.
Journal of Affective Disorders (2021) Vol. 296, pp. 622-634
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top